Welcome to our dedicated page for British Amer SEC filings (Ticker: BTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The British American Tobacco p.l.c. (BTI) SEC filings page brings together the company’s U.S. regulatory disclosures, primarily its annual report on Form 20-F and a series of current reports on Form 6-K. As a foreign private issuer with American Depositary Shares listed on the NYSE, British American Tobacco uses these filings to provide U.S. investors with information on its operations, capital structure, governance and financing activities.
Form 6-K filings for British American Tobacco frequently attach press releases and transaction documents as exhibits. These include announcements on transactions in own shares, details of share buyback programmes and their extensions, and updates on voting rights and capital. Such filings help investors track the evolution of the company’s equity base and the execution of authorised repurchases.
Another important group of filings relates to debt capital markets. British American Tobacco and its financing subsidiaries, such as B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V., use Form 6-K to file underwriting agreements, supplemental indentures, prospectuses and press releases about the pricing of new notes offerings or tender offers for outstanding perpetual subordinated securities. Some of these exhibits are explicitly incorporated by reference into the group’s shelf registration statements on Form F-3, which govern the issuance of registered debt securities in the U.S. market.
Filings also cover governance and regulatory notifications, including TR-1 notifications of major holdings, board and committee changes, and notifications of transactions by persons discharging managerial responsibilities and persons closely associated with them. These documents provide insight into changes in significant shareholdings and the composition of the company’s leadership.
On this page, users can access these filings as they are made available through EDGAR, while AI-powered tools can help summarise lengthy exhibits, highlight key terms in notes offerings or tender offers, and clarify the implications of share buyback and voting rights announcements. This can be particularly useful when reviewing complex documentation such as supplemental indentures or multi-exhibit 6-K submissions.
British American Tobacco p.l.c. files its 2025 Form 20‑F, describing its global tobacco and nicotine business, New Categories strategy and governance under IFRS with KPMG as auditor. The company lists American Depositary Shares and multiple long-dated notes on the New York Stock Exchange and reports 2,312,454,501 ordinary shares outstanding as of year-end.
The filing focuses heavily on risk factors, including competition from illicit trade, geopolitical instability, cyber and digital threats, complex supply chains, climate and circularity pressures, and pandemics. It also highlights extensive regulatory and taxation uncertainty for combustible, smokeless and Beyond Nicotine products, significant litigation and tax exposure, and the importance of talent retention, transformation programs and major ERP migration to support its multi-category growth plans.
British American Tobacco p.l.c. submitted a Form 6-K as a foreign private issuer, providing U.S. investors with information it has released in its home market. The filing, dated February 12, 2026, furnishes a press release titled “Share Buyback Programme.”
The exhibit indicates the company is formally communicating details of a share buyback programme, though this excerpt does not include the financial terms or size of the programme itself. The report is signed on behalf of British American Tobacco by Senior Assistant Company Secretary Nancy Jiang.
British American Tobacco reported mixed 2025 results, with modest underlying growth and heavy Canada-related cash outflows. Group revenue was £25,610 million, down 1.0% reported but up 2.1% at constant currency, driven by combustibles and strong Modern Oral growth, partly offset by weakness in APMEA.
New Categories revenue reached £3,621 million, up 7.0% at constant rates, with smokeless products now 18.2% of total revenue and 34.1 million consumers, up 4.7 million. Adjusted profit from operations as adjusted for Canada rose 2.3% to £11,628 million, while adjusted diluted EPS as adjusted for Canada grew 3.4% at constant rates to 352.8p.
Reported diluted EPS surged 157% to 349.1p, mainly from lower adjusting items including changes to the Canadian litigation provision. Cash generation fell as net cash from operating activities dropped 37.4% to £6,342 million and free cash flow before dividends declined 48.8%, reflecting a £2.6 billion Canada settlement payment and U.S. tax deferrals. Despite this, leverage was 2.48x adjusted net debt/adjusted EBITDA (2.55x as adjusted for Canada), with a target of 2.0–2.5x by end 2026. The dividend increased 2.0% to 245.04p and the company plans a £1.3 billion share buy-back in 2026, while guiding that 2026 performance will likely be at the lower end of its mid-term growth ranges.
British American Tobacco p.l.c. has filed a Form 6-K to furnish a press release titled “British American Tobacco p.l.c. (the “Company” or “BAT”) - Board Update – Chair Extension and Senior Independent Director Appointment,” dated February 10, 2026.
The materials in this report, including the press release, are incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements and related prospectuses.
British American Tobacco p.l.c. filed a Form 6-K summarizing several January 2026 press releases on share-related matters and disclosures by senior managers. The filing also includes a Schedule 5 blocklisting six monthly return for its Sharesave Schemes.
For the period from 1 July 2025 to 31 December 2025, under Sharesave Scheme A, the company issued 38,298 ordinary shares of 25p each, leaving 74,993 shares still available under that blocklisting. Sharesave Scheme B had no shares issued in the period and retained its full 1,500,000 share balance.
As of the end of the period, British American Tobacco reported 2,312,454,501 ordinary shares of 25p each in issue, including 132,988,352 shares held in treasury.
British American Tobacco p.l.c. reports a change in a major institutional holding. The Capital Group Companies, Inc. notified the company that on 22 January 2026 its position fell to 18.869293% of voting rights in British American Tobacco, representing 410,903,888 voting rights in total. This compares with a previously reported level of 19.013003%. The position is held through common stock and depository receipts and does not involve any reportable financial instruments. Capital Group acts as discretionary investment manager for underlying client accounts and states that neither it nor its affiliates hold the shares for their own account.
British American Tobacco p.l.c. is providing a 6-K that bundles multiple December 2025 press releases covering share capital, buybacks, governance and shareholder returns. The exhibits include numerous “Transaction in own shares” announcements, indicating ongoing repurchases and an “Extension of Share Buyback Programme,” as well as a release titled “On track for FY25 delivery; Reaffirming 2026 guidance and announcing a £1.3bn share buy-back.” Other exhibits describe a proposed and completed block trade of ITC Hotels shares, notifications of transactions by senior managers and related parties, quarterly dividend payment information for February 2026, committee changes and notifications in accordance with UK Listing Rule 6.4.9R(2).
British American Tobacco p.l.c. submitted a Form 6-K to provide investors with a press release titled “British American Tobacco p.l.c. (BAT) – Committee Change.” The filing indicates that this press release, included as Exhibit 1, describes a change related to one of the company’s board or board-level committees, although specific details of the change are contained in the exhibit rather than in the core text.
The information in Exhibit 1 is also incorporated by reference into several existing Form S-8 employee share plan registrations and a Form F-3 shelf registration for British American Tobacco and its affiliated issuers. This links the governance-related disclosure to those previously registered securities and their related prospectuses.
British American Tobacco p.l.c. submitted a Form 6-K as a foreign private issuer to provide investors with materials the company published on December 10, 2025. The filing mainly forwards a press release titled “British American Tobacco p.l.c. – Extension of Share Buyback Programme”, indicating that the company has decided to extend its existing share repurchase activity. While this document itself does not include financial terms or buyback amounts, it alerts investors that updated details about the extended share buyback programme are available in the attached press release issued on the same date.
British American Tobacco p.l.c. filed a Form 6-K to furnish a press release titled “On track for FY25 delivery; Reaffirming 2026 guidance and announcing a £1.3bn share buy-back.” The filing indicates that selected portions of this press release are incorporated by reference into several existing Form S-8 and Form F-3 registration statements for the company and certain subsidiaries. The document itself does not include financial statements, but signals that British American Tobacco is confirming its 2026 outlook while also announcing a planned £1.3 billion share repurchase programme.